PRECIVITYTAUDX Trademark

Trademark Overview

On Saturday, December 14, 2024, a trademark application was filed for PRECIVITYTAUDX with the United States Patent and Trademark Office. The USPTO has given the PRECIVITYTAUDX trademark a serial number of 98903251. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, December 14, 2024. This trademark is owned by C2N Diagnostics, LLC. The PRECIVITYTAUDX trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical diagnostic reagents, assays, and algorithms for testing bodily fluids; diagnostic testing kits comprised of diagnostic reagents, assays and specimen holders for testing of bodily fluids for use in disease or pathology detection, diagnosing, staging, predicting future events, predicting or measuring disease progression, assessing treatment response, monitoring, reporting, treating, and prevention, namely, neurodegenerative diseases and neurological diseases

Medical testing for diagnostic, prognostic, monitoring or treatment purposes; medical laboratory, diagnostic testing, disease or pathology staging, predicting, monitoring, and reporting services; medical testing for disease, illness, pathology, and pathology treatment tracking, predicting, treating and prevention purposes
precivitytaudx

General Information

Serial Number98903251
Word MarkPRECIVITYTAUDX
Filing DateSaturday, December 14, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateSaturday, December 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical diagnostic reagents, assays, and algorithms for testing bodily fluids; diagnostic testing kits comprised of diagnostic reagents, assays and specimen holders for testing of bodily fluids for use in disease or pathology detection, diagnosing, staging, predicting future events, predicting or measuring disease progression, assessing treatment response, monitoring, reporting, treating, and prevention, namely, neurodegenerative diseases and neurological diseases
Goods and ServicesMedical testing for diagnostic, prognostic, monitoring or treatment purposes; medical laboratory, diagnostic testing, disease or pathology staging, predicting, monitoring, and reporting services; medical testing for disease, illness, pathology, and pathology treatment tracking, predicting, treating and prevention purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, December 14, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameC2N Diagnostics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSt. Louis, MO 63110

Trademark Events

Event DateEvent Description
Saturday, December 14, 2024NEW APPLICATION ENTERED

Related Keywords

precivitytaudx testing diagnostic pathology medical predicting disease monitoring treatment assays staging